Changes in vascular accesses and in incidence rates of dialysis-related bloodstream infections in Québec, Canada, 2011-2017.


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 9 4 2019
medline: 10 4 2020
entrez: 9 4 2019
Statut: ppublish

Résumé

Surveillance of dialysis-related bloodstream infections (DRBSIs) has been mandatory in Québec since April 2011. The aim of this study was to describe the epidemiology of DRBSIs in Québec. Cohort study of prevalent patients undergoing chronic dialysis in the 36 facilities that participated without interruption in the provincial surveillance, between April 2011 and March 2017. Two indicators were analyzed: proportion of patient months dialyzed using a fistula (a patient month is a 28-day cycle during which an individual patient received dialysis) and incidence rate of DRBSI. Binomial and Poisson regression with generalized estimating equations were used to describe the evolution of indicators over time and to quantify the association between facilities' proportion of fistulas and their incidence rate. Globally, 42.6% of all patient months were dialyzed using a fistula, but there was a statistically significant decrease over time (46.2% in 2011-2012 to 39.3% in 2016-2017). Despite this decline in the use of fistulas, rates of DRBSIs have also decreased, going from 0.38 DRBSIs per 100 patient months in 2011-2012 to 0.23 DRBSIs per 100 patient months in 2016-2017. No association was found between facility use of fistulas and the rate of DRBSI. At the individual level, however, the DRBSI rate was 4.12 times higher for patients using a catheter. In Québec, the rate of DRBSIs has decreased over a 6-year period despite an increasing proportion of patients dialyzed by catheter.

Identifiants

pubmed: 30957725
pii: S0899823X19000655
doi: 10.1017/ice.2019.65
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

627-631

Auteurs

Élise Fortin (É)

Direction des risques biologiques et de la santé au travail,Institut national de santé publique du Québec,Québec,Canada.

Manale Ouakki (M)

Direction des risques biologiques et de la santé au travail,Institut national de santé publique du Québec,Québec,Canada.

Claude Tremblay (C)

Centre hospitalier universitaire (CHU) de Québec,Québec,Canada.

Jasmin Villeneuve (J)

Direction des risques biologiques et de la santé au travail,Institut national de santé publique du Québec,Québec,Canada.

Simon Desmeules (S)

Centre hospitalier universitaire (CHU) de Québec,Québec,Canada.

Natasha Parisien (N)

Direction des risques biologiques et de la santé au travail,Institut national de santé publique du Québec,Québec,Canada.

Danielle Moisan (D)

Centre intégré de santé et de services sociaux (CISSS) du Bas-Saint-Laurent,Québec,Canada.

Charles Frenette (C)

Department of Medical Microbiology,McGill University Health Centre,Québec,Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH